| Natera is a diagnostics company. Co. engages in the discovery, development and commercialization of genetic testing services. Co.'s product offerings include: Panorama Non-Invasive Prenatal Test, which screens for chromosomal abnormalities of a fetus typically with a blood draw from the mother; Vistara, a single-gene mutations screening test performed to identify single-gene disorders; Horizon Carrier Screening, which determines carrier status for a number of severe genetic diseases that could be passed on to the carrier's children; and Spectrum, which analyzes chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos for a pregnancy. We show 22 historical shares outstanding datapoints in our NTRA shares outstanding history coverage, used to compute NTRA market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing NTRA market cap history over the course of time is important for investors
interested in comparing NTRA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of NTRA versus a peer is one thing; comparing
NTRA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like NTRA can fluctuate over the course of history.
With this page we aim to empower investors researching NTRA by allowing them to research the NTRA market cap history.